(Q46052631)

19 December 2017

title

Non-intensive treatment with low-dose 5-aza-2'-deoxycytidine (DAC) prior to allogeneic blood SCT of older MDS/AML patients (English)

1 reference

19 December 2017

author name string

M Lübbert

1

1 reference

19 December 2017

H Bertz

2

1 reference

19 December 2017

B Rüter

3

1 reference

19 December 2017

R Marks

4

1 reference

19 December 2017

R Claus

5

1 reference

19 December 2017

R Wäsch

6

1 reference

19 December 2017

J Finke

7

1 reference

19 December 2017

language of work or name

English

0 references

publication date

13 April 2009

1 reference

19 December 2017

Bone Marrow Transplantation

published in

1 reference

19 December 2017

volume

44

1 reference

19 December 2017

issue

9

1 reference

19 December 2017

page(s)

585-588

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1038/bmt.2009.64

exact match

0 references

cites work

Allogeneic Stem-Cell Transplantation From Related and Unrelated Donors in Older Patients With Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.64

End points to establish the efficacy of new agents in the treatment of acute leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.64

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.64

Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.64

Fatal varicella zoster virus encephalitis in two patients following allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.64

5-Aza-2'-deoxycytidine (decitabine) treatment of hematopoietic malignancies: a multimechanism therapeutic approach?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.64

Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.64

Reduced-toxicity conditioning with fludarabine, BCNU, and melphalan in allogeneic hematopoietic cell transplantation: particular activity against advanced hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.64

Limited gene activation in tumor and normal epithelial cells treated with the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.64

Successful treatment of relapsed AML after allogeneic stem cell transplantation with azacitidine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.64

MODULATION OF HLA-DR ANTIGENS EXPRESSION IN HUMAN MYELOID LEUKAEMIA CELLS BY CYTARABINE AND 5-AZA-2'-DEOXYCYTIDINE

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.64

CDKN2B methylation status and isolated chromosome 7 abnormalities predict responses to treatment with 5-azacytidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.64

7 January 2021

inferred from DOI database lookup

Preferential cytogenetic response to continuous intravenous low-dose decitabine (DAC) administration in myelodysplastic syndrome with monosomy 7

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.64

7 January 2021

inferred from DOI database lookup

Low-dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.64

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/BMT.2009.64

1 reference

19 December 2017

Dimensions Publication ID

1045435788

0 references

Fatcat ID

release_bqitb2cvgnabjdgx5edvxwjtkq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bqitb2cvgnabjdgx5edvxwjtkq

24 November 2022

mapped directly with Wikidata item

PubMed ID

19363531

1 reference

19 December 2017